93 related articles for article (PubMed ID: 10911389)
1. Tributyrin plus all-trans-retinoic acid efficiently induces fetal hemoglobin expression in human erythroleukemia cells.
Witt O; Schmejkal S; Pekrun A
Am J Hematol; 2000 Aug; 64(4):319-21. PubMed ID: 10911389
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
3. [Role of aquaporin-1 gene in erythroid differentiation of erythroleukemia K562 cells induced by retinoic acid].
Wei M; Shi R; Jiang L; Wang N; Ma W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1689-94. PubMed ID: 23268390
[TBL] [Abstract][Full Text] [Related]
4. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy.
Chen ZX; Breitman TR
Cancer Res; 1994 Jul; 54(13):3494-9. PubMed ID: 8012972
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid.
Suedhoff T; Birckbichler PJ; Lee KN; Conway E; Patterson MK
Cancer Res; 1990 Dec; 50(24):7830-4. PubMed ID: 1979250
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers loaded with tributyrin as an alternative to improve anticancer activity of all-trans retinoic acid.
Silva EL; Carneiro G; Caetano PA; Goulart G; Ferreira Costa D; de Souza-Fagundes EM; Gomes DA; Ferreira LA
Expert Rev Anticancer Ther; 2015 Feb; 15(2):247-56. PubMed ID: 25611812
[TBL] [Abstract][Full Text] [Related]
7. Combined use of nonmyelosuppressive nitrosourea analogues with hydroxyurea in the induction of F-cell production in a human erythroleukemic cell line.
Iyamu EW; Adunyah SE; Fasold H; Horiuchi K; Baliga S; Ohene-Frempong K; Turner EA; Asakura T
Exp Hematol; 2003 Jul; 31(7):592-600. PubMed ID: 12842704
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of retinoic acid-induced differentiation of human acute promyelocytic leukemia NB4 cells by butyric acid, tributyrin, and hexamethylene bisacetamide.
Taimi M; Chen ZX; Breitman TR
Oncol Res; 1998; 10(2):75-84. PubMed ID: 9666515
[TBL] [Abstract][Full Text] [Related]
9. Growth inhibitory and differentiation effects of chloroquine and its analogue on human leukemic cells potentiate fetal hemoglobin production by targeting the polyamine pathway.
Iyamu E; Perdew H; Woods G
Biochem Pharmacol; 2009 Mar; 77(6):1021-8. PubMed ID: 19073155
[TBL] [Abstract][Full Text] [Related]
10. Novel valproic acid derivatives with hemoglobin F inducing activity.
Rönndahl G; Mönkemeyer S; Schulze S; Pekrun A; Eikel D; Nau H; Witt O
Am J Hematol; 2006 May; 81(5):374-6. PubMed ID: 16628726
[TBL] [Abstract][Full Text] [Related]
11. Mouse fetal hemoglobin synthesis in murine erythroleukemic cells.
Wu NC; Zucker RM
FEBS Lett; 1979 Mar; 99(2):299-302. PubMed ID: 284927
[No Abstract] [Full Text] [Related]
12. Specific erythroid differentiation of mouse erythroleukemia cells by activins and its enhancement by retinoic acids.
Uchiyama H; Asashima M
Biochem Biophys Res Commun; 1992 Aug; 187(1):347-52. PubMed ID: 1520319
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin.
Iyamu WE; Adunyah SE; Fasold H; Horiuchi K; Elford HL; Asakura T; Turner EA
Am J Hematol; 2000 Apr; 63(4):176-83. PubMed ID: 10706760
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
Zhang M; Guo R; Xu H; Zhang M; Li B
Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
[TBL] [Abstract][Full Text] [Related]
15. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells.
Hatse S; De Clercq E; Balzarini J
Mol Pharmacol; 1996 Nov; 50(5):1231-42. PubMed ID: 8913355
[TBL] [Abstract][Full Text] [Related]
16. New designed HMBA agents as inducers of erythroleukemia cell differentiation.
Wang H; Zhang S; Zhou J; Zhang J
Chin Med Sci J; 2002 Mar; 17(1):27-31. PubMed ID: 12894881
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea induces a senescence-like change of K562 human erythroleukemia cell.
Park JI; Jeong JS; Han JY; Kim DI; Gao YH; Park SC; Rodgers GP; Kim IH
J Cancer Res Clin Oncol; 2000 Aug; 126(8):455-60. PubMed ID: 10961388
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin D induces fetal hemoglobin synthesis in K562 cells and human hematopoietic progenitors through activation of p38 pathway and stabilization of the γ-globin mRNA.
Liu K; Xing H; Zhang S; Liu Sm; Fung Mc
Blood Cells Mol Dis; 2010 Dec; 45(4):269-75. PubMed ID: 20926322
[TBL] [Abstract][Full Text] [Related]
19. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.
Martin P; Papayannopoulou T
Science; 1982 Jun; 216(4551):1233-5. PubMed ID: 6177045
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human hemoglobin switching in MEL x human fetal erythroid cell hybrids.
Papayannopoulou T; Brice M; Stamatoyannopoulos G
Cell; 1986 Aug; 46(3):469-76. PubMed ID: 2425983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
